Adverum生物技術 ADVM 深 滬
交易中 09-20 10:54:22 美东时间
7.485
-0.015
-0.20%
華盛通- 最 高7.54
- 今 開7.42
- 成交量 4.89万股
- 最 低 7.42
- 昨 收 7.50
- 總市值 1.55亿
- 52周最高 29.70
- 市盈率 靜 --
- 換手率 0.24%
- 52周最低 6.38
- 委 比 48.39%
- 總股本 2075.49万
- 歷史最高 624.80
- 量 比 1.38
- 振 幅 1.60%
- 歷史最低 5.31
- 每 手 1
- 風險率 4.18%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多快讯 | Adverum Biotechnologies公司：瑞穗将目标价从22美元降至20美元。
Adverum Biotechnologies Inc : Mizuho Cuts Target Price to $20 From $22
08-19 19:16
快讯 | adverum biotechnologies公司：Truist Securities将目标价从60美元下调至40美元
Adverum Biotechnologies Inc : Truist Securities Cuts Target Price to $40 From $...
08-14 11:32
Analysts’ Top Healthcare Picks: Adverum Biotechnologies (ADVM), Astria Therapeutics (ATXS)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts jus...
08-13 18:22
快讯 | adverum biotechnologies公司：RBC将目标价从15美元降至12美元。
Adverum Biotechnologies Inc : RBC Cuts Target Price to $12 From $15
08-13 14:42
Adverum Biotechnologies Q2 2024 Adj EPS $(0.89) Beats $(1.47) Estimate
Adverum Biotechnologies (NASDAQ:ADVM) reported quarterly losses of $(0.89) per share which beat the analyst consensus estimate of $(1.47) by 39.46 percent.
08-13 04:18
快讯 | adverum biotechnologies公司: 预计现金将资助经营活动直至2025年底。
Adverum Biotechnologies Inc: Cash Expected to Fund Operations Into Late 2025
08-13 04:11
快讯 | adverum biotechnologies 报告2024年第二季度财务业绩和项目及公司亮点。
Adverum Biotechnologies Reports Second Quarter 2024 Financial Results and Provi...
08-13 04:05
Around $88M Bet On NextDecade? Check Out These 3 Stocks Insiders Are Buying
Although U.S. stocks closed higher on Thursday, there were a few notable inside...
08-01 20:47
快讯 | adverum biotechnologies宣布，ixo-vec获得治疗湿性年龄相关性黄斑变性的FDA再生医学先进疗法(RMAT)认定。
Adverum Biotechnologies Announces FDA Regenerative Medicine Advanced Therapy (R...
08-01 20:00
美股牛股 | 能链智电暴涨53%！周内股价接近翻倍；霍顿房屋绩后飙升10%
“无人驾驶”概念股能链智电再度暴涨53%！周内股价接近翻倍；霍顿房屋绩后飙升10%，拟斥资40亿美元回购股票>>
07-19 19:25
